NS398, a cyclooxygenase-2 inhibitor, reverses memory performance disrupted by imipramine in C57Bl/6J mice
- 20 February 2020
- journal article
- research article
- Published by Elsevier BV in Brain Research
- Vol. 1734, 146741
- https://doi.org/10.1016/j.brainres.2020.146741
Abstract
No abstract availableKeywords
Funding Information
- National Science Centre, Poland
- Maj Institute of Pharmacology, PAS, Poland
This publication has 57 references indexed in Scilit:
- The differential effects of chronic imipramine or citalopram administration on physiological and behavioral outcomes in naïve miceBehavioural Brain Research, 2013
- Critical role of cPLA2 in Aβ oligomer-induced neurodegeneration and memory deficitNeurobiology of Aging, 2012
- Synaptic and Extrasynaptic NMDA Receptors Differentially Modulate Neuronal Cyclooxygenase-2 Function, Lipid Peroxidation, and NeuroprotectionJournal of Neuroscience, 2011
- Altered mRNA Editing and Expression of Ionotropic Glutamate Receptors after Kainic Acid Exposure in Cyclooxygenase-2 Deficient MicePLOS ONE, 2011
- Dscam Mediates Remodeling of Glutamate Receptors in Aplysia during De Novo and Learning-Related Synapse FormationNeuron, 2009
- Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to ‘switching’ in bipolar disorder?Molecular Psychiatry, 2008
- Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brainBrain, Behavior, and Immunity, 2008
- Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticityBrain, 2008
- Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NOLearning & Memory, 2007
- Depressed In-Patients Respond Differently to Imipramine and MirtazapinePharmacopsychiatry, 1999